Neuromedicine

Download PDF (152.4 KB) PP. 9 - 12 Pub. Date: November 3, 2018

DOI:

• Anna Titkova^*
  Laboratory of Neurophysiology, Immunology and Biochemistry, Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine, Ukraine
• Olga Berchenko
  Laboratory of Neurophysiology, Immunology and Biochemistry, Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine, Ukraine

The purpose of the research was to study the effects of neurotransplantation of embryonic nervous tissues (ENT) and electrostimulation of subthalamic nucleus (STN) on catecholamine contents in nucleus caudatus in rats with electrolytic lesion of substantia nigra (SNc). The following methods were used: the model of nigrostriatal failure created by electrolytic lesion of SNc in rats; transplantation of rat brain ENT into nucleus caudatus; electrostimulation of STN with low intensity current. Transplantation of ENT into nucleus caudatus contributes to the recovery of movement disorders and dopamine levels in nucleus caudatus disturbed as a result of SNc lesion. Electrostimulation of STN significantly enhances the effect of neurotransplantation and is accompanied with the increase of content and metabolism of dopamine in nucleus caudatus. Electrostimulation of STN with low intensity current creates additional conditions for compensation of dopamine deficiency in nucleus caudatus after neurotransplantation in rats with nigrostriatal failure.

Movement disorders, neurotransplantation of embryonic tissue, electrostimulation of STN, nucleus caudatus, catecholamines.

[1] T. Wichmann, H.Bergman, and M.R.DeLong, “The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism,” Journal of neurohhysiology, vol. 72, no. 2, pp. 521-530, 1994.

[2] W.Dauer and S.Przedborski, “Parkinson’s disease: mechanisms and models,”Neuron, vol. 39, pp. 889-909, 2003.

[3] A.Bjorklund, “Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery,” Current opinions in neurobiology, vol. 2, pp. 683-689, 1992.

[4] M.V.Ugrumov, “Neurotransplantation in treatment of Parkinson’s disease.” in Basal ganglia and thalamus in health and movement disorders,” Kluwer, 2001, pp. 349-363.

[5] O.Berchenko and Y.Usmentseva, “Recovery of nigrostriatal dopaminergic system insufficiency by allotransplantation of embryonic brain tissue,” World journal of neuroscience, no. 3, pp. 240-245, 2013.

[6] V.C.Anderson, K.Burchiel, P.Hogarth, J.Favre, and J.P.Hammerstad, “Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease,” Archive of neurology, vol. 62, pp. 554-560, 2005.”

[7] D.Drago, C.Cossetti, N.Iraci, E.Gaude, G.Musco, A.Bachi, and S.Pluchino, “The stem cell secretome and its role in brain repair,” Biochimie, vol. 95, pp. 2271-2285, 2013.

[8] J.Bures, M.Petran, and J.Zachar,“Electrophysiological methods in biological research,” Ed.2 Publishing House. 1960.

[9] A.Parent and L.-N.Hazrati, “Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry,” Brain research reviews, vol. 20, no. 1, pp. 128-154, 1995.

[10] Y.Temel, A.Blockland, H.Steinbusch, and V.Vandewalle, “The functional role of the subthalamic nucleus in cognitive and limbic circuits,” Progress in neurobiology, vol. 76, no. 6, pp. 393-413, 2005.

[11] E.Kadar, L.W.Lim, G.Carreras, D.Genis, Y.Temel, and G.Huguet, “High-frequency stimulation of the ventrolateral thalamus regulates gene expression in hippocampus, motor cortex and caudate-putamen,” Brain research, vol. 1391, pp. 1-13, 2011.